CING — what changed in the latest 10-Q
A section-by-section comparison of CING's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-14 vs the prior 10-Q · 2025-11-13
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +66 | −62 | ~13 | 33 |
| Market risk (Item 3) | Text added/removed | +66 | −62 | ~12 | 33 |
| Controls & procedures | Text added/removed | +66 | −62 | ~12 | 33 |
| Legal proceedings | Text added/removed | +66 | −62 | ~12 | 33 |
| Risk factors | Text added/removed | +66 | −62 | ~12 | 33 |
| Other information | Text added/removed | +66 | −62 | ~11 | 33 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-14
our ability to obtain approval for CTx-1301 and the timing of any such approval;
Net loss per share of common stock, basic and diluted $(0.95) $(1.06)
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 9,777,786 3,646,893
Shares Amount Shares Amount Paid-in-Capital Deficit Income Equity
Common Stock Preferred Stock Additional Accumulated Other Comprehensive Stockholders’
Text removed vs the prior filing · source: 10-Q · 2025-11-13
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024 - -
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 5,431,206 1,766,362 4,495,724 936,118
Common Stock Additional Paid-in- Accumulated Accumulated Other Comprehensive Stockholders’
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees 23,650 2 3,115,282 - - 3,115,284
Issuance of pre-funded warrants in connection with the conversion of related party note payable - - 2,734,739 - - 2,734,739
Market risk (Item 3)
Text added vs the prior filing · source: 10-Q · 2026-05-14
our ability to obtain approval for CTx-1301 and the timing of any such approval;
Net loss per share of common stock, basic and diluted $(0.95) $(1.06)
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 9,777,786 3,646,893
Shares Amount Shares Amount Paid-in-Capital Deficit Income Equity
Common Stock Preferred Stock Additional Accumulated Other Comprehensive Stockholders’
Text removed vs the prior filing · source: 10-Q · 2025-11-13
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024 - -
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 5,431,206 1,766,362 4,495,724 936,118
Common Stock Additional Paid-in- Accumulated Accumulated Other Comprehensive Stockholders’
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees 23,650 2 3,115,282 - - 3,115,284
Issuance of pre-funded warrants in connection with the conversion of related party note payable - - 2,734,739 - - 2,734,739
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-05-14
our ability to obtain approval for CTx-1301 and the timing of any such approval;
Net loss per share of common stock, basic and diluted $(0.95) $(1.06)
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 9,777,786 3,646,893
Shares Amount Shares Amount Paid-in-Capital Deficit Income Equity
Common Stock Preferred Stock Additional Accumulated Other Comprehensive Stockholders’
Text removed vs the prior filing · source: 10-Q · 2025-11-13
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024 - -
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 5,431,206 1,766,362 4,495,724 936,118
Common Stock Additional Paid-in- Accumulated Accumulated Other Comprehensive Stockholders’
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees 23,650 2 3,115,282 - - 3,115,284
Issuance of pre-funded warrants in connection with the conversion of related party note payable - - 2,734,739 - - 2,734,739
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-05-14
our ability to obtain approval for CTx-1301 and the timing of any such approval;
Net loss per share of common stock, basic and diluted $(0.95) $(1.06)
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 9,777,786 3,646,893
Shares Amount Shares Amount Paid-in-Capital Deficit Income Equity
Common Stock Preferred Stock Additional Accumulated Other Comprehensive Stockholders’
Text removed vs the prior filing · source: 10-Q · 2025-11-13
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024 - -
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 5,431,206 1,766,362 4,495,724 936,118
Common Stock Additional Paid-in- Accumulated Accumulated Other Comprehensive Stockholders’
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees 23,650 2 3,115,282 - - 3,115,284
Issuance of pre-funded warrants in connection with the conversion of related party note payable - - 2,734,739 - - 2,734,739
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-05-14
our ability to obtain approval for CTx-1301 and the timing of any such approval;
Net loss per share of common stock, basic and diluted $(0.95) $(1.06)
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 9,777,786 3,646,893
Shares Amount Shares Amount Paid-in-Capital Deficit Income Equity
Common Stock Preferred Stock Additional Accumulated Other Comprehensive Stockholders’
Text removed vs the prior filing · source: 10-Q · 2025-11-13
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024 - -
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 5,431,206 1,766,362 4,495,724 936,118
Common Stock Additional Paid-in- Accumulated Accumulated Other Comprehensive Stockholders’
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees 23,650 2 3,115,282 - - 3,115,284
Issuance of pre-funded warrants in connection with the conversion of related party note payable - - 2,734,739 - - 2,734,739
Other information
Text added vs the prior filing · source: 10-Q · 2026-05-14
our ability to obtain approval for CTx-1301 and the timing of any such approval;
Net loss per share of common stock, basic and diluted $(0.95) $(1.06)
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 9,777,786 3,646,893
Shares Amount Shares Amount Paid-in-Capital Deficit Income Equity
Common Stock Preferred Stock Additional Accumulated Other Comprehensive Stockholders’
Text removed vs the prior filing · source: 10-Q · 2025-11-13
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024 - -
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted 5,431,206 1,766,362 4,495,724 936,118
Common Stock Additional Paid-in- Accumulated Accumulated Other Comprehensive Stockholders’
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees 23,650 2 3,115,282 - - 3,115,284
Issuance of pre-funded warrants in connection with the conversion of related party note payable - - 2,734,739 - - 2,734,739
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice